$ISIS Recent News S&P confirms uptrend, pulls in from

New Post Public Reply Private Reply Replies (0) Message Board

Jan 6, 2015 at 10:00 AM

$ISIS Recent News

S&P confirms uptrend, pulls in from record high 10:59 a.m. Nov. 19, 2014 - Michael Ashbaugh
Strong bull trend absorbs Fed-induced whipsaw 9:59 a.m. Oct. 30, 2014 - Michael Ashbaugh
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 11:01 p.m. Sept. 1, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 8:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 10:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt

Isis Pharmaceuticals (ISIS) in Focus: Stock Soars 10.7% - Tale of the Tape 39 min ago - Zacks.com
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015 8:30 a.m. Today - TheStreet.com
Jim Cramer's Top Stock Picks: INTC UNH HD MSFT CSCO ISIS 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: My 10 Ways to Make Your 2014 Gains Continue in 2015 8:27 p.m. Jan. 5, 2015 - TheStreet.com
Hot Biotech Stocks: Isis, Kite Jump On Big Deals 5:20 p.m. Jan. 5, 2015 - Investors Business Daily
3 Drugs Stocks Nudging The Industry Higher 1:08 p.m. Jan. 5, 2015 - TheStreet.com
Isis Pharma To Develop GI Drugs With J&J 12:17 p.m. Jan. 5, 2015 - Investors Business Daily
Jim Cramer: Isis Pharmaceuticals Gets a 'Gigantic' Boost With J&J Deal 11:53 a.m. Jan. 5, 2015 - TheStreet.com
Why Boston Scientific, ISIS Pharmecuticals, and RCS Capital are 3 of Today’s Best Stocks 10:55 a.m. Jan. 5, 2015 - InvestorPlace.com
Today's Market: Biotech Names Rallying, Retail Buyout Candidates 10:08 a.m. Jan. 5, 2015 - Seeking Alpha
Isis Pharmaceuticals (ISIS) Off To A Strong Start In Pre-Market Activity 7:59 a.m. Jan. 5, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ISIS BSX MNKD BLUE 7:00 a.m. Jan. 5, 2015 - InvestorPlace.com
Will Biotech Fire On All Cylinders In 2015? 4:15 p.m. Dec. 30, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ISIS NBIX CLDX EXAS 6:15 a.m. Dec. 26, 2014 - InvestorPlace.com
Isis Pharmaceuticals (ISIS) Showing Signs Of A Dead Cat Bounce Today 9:56 a.m. Dec. 24, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ACHN BLUE ISIS HALO 7:00 a.m. Dec. 24, 2014 - InvestorPlace.com
Isis Pharmaceuticals (ISIS) Stock: Weak On High Volume Today 10:04 a.m. Dec. 23, 2014 - TheStreet.com
Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half 10:46 a.m. Dec. 19, 2014 - TheStreet.com
Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape 9:00 a.m. Dec. 19, 2014 - Zacks.com
Hottest Healthcare Stocks Now – PBYI HALO ISIS PRGO 6:30 a.m. Dec. 19, 2014 - InvestorPlace.com

Critical Alerts For JetBlue, Isis Pharmaceuticals, Gold Fields, 58.com and 51job Released By InvestorsObserver 29 min ago - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Today - PR Newswire - PRF
Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics 7:00 a.m. Today - PR Newswire - PRF
Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer 6:00 p.m. Jan. 5, 2015 - PR Newswire - PRF
Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract 7:00 a.m. Jan. 5, 2015 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference 11:00 a.m. Jan. 2, 2015 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1 7:00 a.m. Dec. 16, 2014 - PR Newswire - PRF
Critical Alerts For Mobileye NV, bluebird bio Inc., Isis Pharmaceuticals, Castlight Health and ConocoPhillips Released By InvestorsObserver 9:31 a.m. Dec. 9, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery 2:05 p.m. Dec. 7, 2014 - PR Newswire - PRF
Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award 7:00 a.m. Dec. 5, 2014 - PR Newswire - PRF
Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma 8:50 a.m. Dec. 4, 2014 - PR Newswire - PRF
ISIS-APOCIII Rx Phase 2 Study in Patients With Familial Chylomicronemia Published in the New England Journal of Medicine 5:05 p.m. Dec. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy 7:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium 4:47 p.m. Nov. 20, 2014 - PR Newswire - PRF
Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association 3:45 p.m. Nov. 18, 2014 - BusinessWire - BZX
Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 7:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Cure SMA Presents Isis Pharmaceuticals with SMA Breakthrough Award 12:04 p.m. Nov. 17, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at Upcoming Investor Conferences 7:00 a.m. Nov. 14, 2014 - PR Newswire - PRF
AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods 3:01 a.m. Nov. 13, 2014 - PR Newswire - PRF
Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Air Sealing First: Boosting Home Comfort & Efficiency

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...